Publication: Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study
Loading...
Identifiers
Date
2007-06-19
Authors
Carabante-Ocón, F
Saez-Lara, E
Burgos-Garcia, L
Villar-Chamorro, E
Casaus-Hazañas, A
Luna, S
Martínez, C
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
Metrics
Export
Abstract
Objective: To study the benefit of trastuzumab in monotherapy or combined with different chemotherapeutic agents in the treatment for Her2+ metastatic breast cancer (MBC) patients after progression on prior trastuzumab therapy.
Description
MeSH Terms
Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Retreatment
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Retreatment
DeCS Terms
CIE Terms
Keywords
trastuzumab, her2-positive, chemotherapies, MBC, neoplasias de la mama, Retratamiento
Citation
Carabante-Ocón F, Saez-Lara E, Burgos-Garcia L, Villar-Chamorro E, Casaus-Hazañas A. Luna S, et al. Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study. Breast Cancer Research. 2007 Jun;9 Supplement 1:s17-8